Extended-Release Niacin Blocks Postprandial HDL Reduction - Medscape

Extended-Release Niacin Blocks Postprandial HDL Reduction Medscape One-time dosing with either 1 or 2 g of extended-release (ER) niacin mitigated this decline in drug-naïve subjects. These findings suggest that there are acute pharmacodynamic effects of niacin that are underexplored, said M. Haris Usman, MD, ...

Doctors Find Less Need For Abbott's 'Good Cholesterol' Pill - Forbes

Forbes

Doctors Find Less Need For Abbott's 'Good Cholesterol' Pill Forbes So much was the case that Niaspan, the extended release formulation of generic niacin, was last year at this time headed to sales of $1 billion a year – blockbuster status. Then along came The National Heart, Lung, and Blood Institute of the National ... and more »

Cardium Presents First Quarter 2012 Financial Results and Recent Developments - PR Newswire (press release)

Cardium Presents First Quarter 2012 Financial Results and Recent Developments PR Newswire (press release) ... which are involved with the release of endogenous growth factors. Cardium's market research indicates that physicians seek easy-to-use products to reduce preparation time and facilitate product application, and Excellagen's syringe-based collagen ... and more »

Cardium Presents First Quarter 2012 Financial Results and Recent Developments - MarketWatch (press release)

Cardium Presents First Quarter 2012 Financial Results and Recent Developments MarketWatch (press release) ... which are involved with the release of endogenous growth factors. Cardium's market research indicates that physicians seek easy-to-use products to reduce preparation time and facilitate product application, and Excellagen's syringe-based collagen ... and more »

Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript - Seeking Alpha

Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript Seeking Alpha We want to open as always with the forward-looking statement language that's set out at the conclusion of this morning's press release. All statements made on this call about future events, results, performance, products under development, ... and more »